El interés en corto de Lyell Immunopharma da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Lyell Immunopharma. Los datos de interés en corto se actualizan cada dos semanas.

Lyell Immunopharma (NASDAQ:LYEL) Bolsa, Informe de interés en corto

LYELL IMMUNOPHARMA INC

Lyell Immunopharma

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

WIIM

MINM

FiEE  shares are trading higher after the company entered into an asset purchase agreement with Suzhou Yixuntong to acquire intellectual property and fixed assets for $1.4 million

News

General

LXFR

Luxfer Completes The Divesture Of Its Graphic Arts Business To Vulcan Metals Specialty Products; Terms Not Disclosed

Shares of Webull Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) soared on Wednesday on exceptionally high trading volume. The stock saw more than 25 million shares change hands, significantly outpacing its 100-day average volume of approximately 9.9 million shares. Here&#8217;s what investors <a href="https://www.benzinga.com/quote/BULL/news">need to know</a>.
What To Know: Wednesday&#8217;s surge appears to be in sympathy with a broader rally in the retail brokerage and crypto sectors. Peer capital markets company Robinhood Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) reached a <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46225339/robinhood-stock-surges-to-all-time-high-on-aggressive-crypto-expansion-whats-going-on">new all-time high</a> Wednesday. 
Robinhood stock has surged in recent sessions amid announcements of an aggressive expansion into cryptocurrency services in Europe and a bullish price target upgrade to $110 from KeyBanc Capital Markets. Analysts <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46225339/robinhood-stock-surges-to-all-time-high-on-aggressive-crypto-expansion-whats-going-on">cited</a> Robinhood&#8217;s &#8220;first-rate innovation&#8221; and international growth potential as key drivers for the positive outlook.
Further fueling the momentum is the robust performance of the cryptocurrency market. The success of spot Bitcoin and Ethereum ETFs, which have attracted billions in inflows, has boosted investor sentiment. 
Analysts at Bloomberg have <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46228970/blackrocks-bitcoin-etf-surpasses-sp-500-etf-in-revenue-as-xrp-dogecoin-etf-approval-predicted-to-follow-soon">raised their odds</a> for the approval of several new altcoin ETFs to over 90% by the end of 2025. With the successful launch of the first spot Solana staking ETF, the market&#8217;s appetite for crypto-related assets appears to be growing, providing a strong tailwind for platforms like Webull.
Webull investors on Wednesday are likely betting that the booming interest in digital assets will directly benefit platforms like it, which offer crypto trading, by driving higher user engagement and revenue.
What Else: Based on <a href="https://www.benzinga.com/news/25/05/45591857/webull-bull-shares-slide-following-q1-earnings-report">first-quarter results</a> reported in May, the company showcased strong top-line growth, with revenues jumping nearly 32% year-over-year to $117.4 million, despite a reported net loss of six cents per share.
Webull also highlighted significant underlying momentum in that report, with customer assets climbing 45% to $12.6 billion and registered users increasing by 17% to 24.1 million.
BULL Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Webull shares closed higher by 11.54% to $14.01 on Wednesday. BULL has a 52-week high of $79.56 and a 52-week low of $10.18.
Read Also: <a href="https://www.benzinga.com/pressreleases/25/06/n46115610/webull-re-enters-crypto-market-with-launch-in-brazil">Webull Re-Enters Crypto Market With Launch In Brazil</a>
<h1 class="wp-block-heading">How To Buy BULL Stock</h1>
By now, you're likely curious about how to participate in the market for Webull, be it to purchase shares or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading — either way, it allows you to profit off of the share price decline.
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

BULL

HOOD

Webull Stock Jumps 11% Wednesday: What Happened?

TROOPS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) (the "Company" or "TROOPS") today announced that the Company has received a judgement (the "Judgement") issued by the High Court of Hong Kong Special Administrative Region Court of First Instance in connection with the action no. HCA 938/2022.
As previously disclosed, on August 9, 2022, TROOPS, Inc. (the "Company") and certain subsidiaries of the Company, including First Asia Finance Limited, SGOCO International (HK) Limited, Suns Tower Limited and Giant Connection Limited (the "Subsidiaries") were included amongst other Defendants and served with a writ of summons in Hong Kong (HCA 938 of 2022) and received injunctions dated August 5, 2022, issued by the High Court of the Hong Kong Special&nbsp;Administrative Region Court of First Instance in connection with the writ of summons. Pursuant to the injunctions, the Company and SGOCO International (HK) Limited cannot remove any of its assets worldwide and cannot dispose of or deal with or diminish the value of any of its assets worldwide up to certain amounts; First Asia Finance Limited, Suns Tower Limited and Giant Connection Limited, cannot remove any of its assets which are within Hong Kong and cannot dispose of or deal with or diminish the value of any of its assets within Hong Kong up to certain amounts. On January 26, 2023, the counsel for the Company and the Subsidiaries received a statement of claim under the above proceedings, whereby the plaintiffs' alleged claims included unlawful means of conspiracy and other claims. The plaintiffs sought relief including damages and equitable compensation, among others. On August 26, 2022, the Company applied for a discharge of the injunction, and court proceedings were subsequently held from May, 2023 to June, 2023. On September 19, 2023, an order issued by the High Court of the Hong Kong Special Administrative Region Court of First Instance dated August 22, 2023 (the "Order") was filed. Pursuant to the Order, amongst others, several injunctions against the Defendants, including the Company, were discharged: (i) the injunction order dated August 5, 2022 prohibiting disposal of assets worldwide against the Company and SGOCO&nbsp;International&nbsp;(HK) Limited was discharged; (ii) the injunction order dated August 5, 2022 prohibiting disposal of assets in Hong Kong against First Asia Finance Limited, Suns Tower Limited and Giant Connection Limited was discharged. The following conditions, amongst others, were imposed by the Order instead: (i) Suns Tower Limited must not in anyway dispose of or deal with or diminish the value of the property known as No. 8 Fui&nbsp;Yiu&nbsp;Kok&nbsp;Street,&nbsp;Tsuen Wan, New Territories; (ii) The Company must not in anyway dispose of or deal with or diminish the value of shares in Giant Connection Limited; and (iii) Giant Connection Limited must not in anyway dispose of or deal with or diminish the value of shares in Paris Sky Limited and 11 Hau Fook Street Limited. Application for security for costs was made by the Company on April 21, 2023. It was ordered on August 22, 2023 that the Plaintiffs do pay HK$1,500,000&nbsp;into Court on or before October 3, 2023 as security for the Company's costs up to and including the stage of exchange of witness statements. The Company believes the lawsuit is without merit and intends to defend the case vigorously. As of the date of this report, the Company was unable to estimate a range of&nbsp;loss, if any, that could result were there to be an adverse final decision in this case.
On June 23, 2025, a judgement (the "Judgement") issued by the High Court of Hong Kong Special Administrative Region Court of First Instance in connection with the action no. HCA 938/2022 mentioned above was filed, whereby it was ordered, amongst others, that:
(i)&nbsp; The Company and the subsidiaries, SGOCO International (HK) Limited and Giant Connection Limited, amongst other defendants, are jointly and severally liable for payment of $163,400,000 Hong Kong Dollars; and
(ii)&nbsp; The Company and the subsidiary, SGOCO International (HK) Limited, amongst other defendants, are jointly and severally liable for payment of $241,400,000 Hong Kong Dollars.
The Judgment is expected to have an impact on the Company's consolidated performance. Further disclosure will be released if any matters requiring disclosure should occur in the future.
Management of the Company (the "Management") expresses profound disappointment with the Court's ruling, which stems from allegations advanced by FTI Consulting as liquidators. As part of the restructuring plan which was disputed by the Plaintiff and&nbsp;alleged to be a fraudulent scheme, the group prudently divested low-value assets including Boca International Limited and Century Skyway Limited. These entities were strategically exited or subsequently deregistered before they could inflict operational or financial harm on the Company and its investors.&nbsp;
The Company, upon careful examination of the content of the Judgement, is looking into options including filing a Notice of Appeal. The Company will pursue all legal avenues to rectify this judgement. The Management is confident in successfully pursuing the appeal and class action to protect the interest of our shareholders.
After thorough legal review, the Company is planning to actively mobilize shareholders to initiate a class-action lawsuit against FTI Consulting in U.S. courts for malicious prosecution and investor harm. Shareholders seeking to join this action are invited to register interest immediately at:&nbsp;<a href="mailto:ir@troops.co">ir@troops.co</a>.

Legal

TROO

TROOPS Inc. Receives HK$404.8M Judgment From Hong Kong Court On June 23, 2025 In HCA 938/2022 Case; Company Plans Appeal And Considers U.S. Class Action

FiEE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MINM#NASDAQ">MINM</a>) ("FiEE" or the "Company"), a technology company integrating IoT, connectivity and AI to redefine brand management solutions in the digital era, is pleased to announce that on June 30, 2025, it entered into an asset purchase agreement with Suzhou Yixuntong Network Technology Co., Ltd. ("Yixuntong") to acquire intellectual property and fixed assets for a total purchase price of USD1,400,000 (the "Acquisition"). The Acquisition was structured as a simultaneous sign and close transaction which closed on June 30, 2025.

FiEE Enters Into Asset Purchase Agreement With Suzhou Yixuntong To Acquire Intellectual Property And Fixed Assets For $1.40M

National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) reported quarterly earnings of $0.48 per share which met the analyst consensus estimate. This is a 2.13 percent increase over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $314.000 million which beat the analyst consensus estimate of $303.260 million by 3.54 percent. This is a 5.61 percent increase over sales of $297.315 million the same period last year.

Earnings

Earnings Beats

FIZZ

National Beverage Q4 EPS $0.48, Inline, Sales $314.000M Beat $303.260M Estimate

OPOF

Old Point Financial Shareholders Approve Company And Old Point National Bank Merger Into TowneBank.

Borr Drilling Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>, ", Borr", , ", Borr Drilling", or the ", Company", ))) has announced today that the Company has received commitments from certain commercial banks to: 1) increase existing super senior RCF (SSRCF) to $200 million; 2) reallocate the existing $45 million Guarantee Facility from super senior to senior secured (freeing up $45 million of capacity under the SSRCF); &nbsp;and 3) add a new $35 million senior secured RCF, subject to a $100 million equity raise. Additionally, the Company has obtained more favorable terms on the financial covenants in these facilities, including a reduction in the minimum liquidity covenant.
The changes to the facilities, together with a proposed $100 million equity raise separately announced by the Company, are expected to increase the Company's available liquidity by more than $200 million. Together, these moves would strengthen the Company's financial position in order to support continued execution of its long-term strategy as well as the pursuit of potential value-added growth opportunities and industry consolidation.

Financing

BORR

Borr Drilling Boosts Liquidity By Over $200M With Expanded Credit Facilities And $100M Equity Raise To Support Growth Strategy

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FLOOF">Flower One Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FLOOF#OTC">FLOOF</a>) shares closed up 900.00% at $1e-05</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 66.67% at $0.001</li>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed up 60.00% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 50.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 34.42% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 17.65% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 17.24% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed up 14.20% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 13.85% at $0.49</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed up 11.17% at $0.57</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 8.24% at $7.75</li>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed up 6.37% at $0.20</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed up 6.22% at $0.92</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 5.45% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 5.33% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Growth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 5.31% at $1.19</li>
<li><a href="https://www.benzinga.com/quote/CRON">Cronos Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed up 3.65% at $2.00</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 3.03% at $1.38</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 54.32% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNGGF">Cann Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNGGF#OTC">CNGGF</a>) shares closed down 35.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 19.79% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 17.00% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 15.03% at $3.76</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 9.60% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 8.29% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 5.11% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 3.70% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 3.52% at $3.84</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

BLGVF

CBDY

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CNBX

CNGGF

CNTMF

CRBP

CRON

CVSI

ELLXF

FFNTF

FLOOF

GNLN

KAYS

LMLLF

LVRLF

MGWFF

MRMD

RMHB

RSSFF

SOLCF

TCNNF

TGIFF

TLRY

YCBD

ZDPY

Marijuana Stock Movers For July 2, 2025

Management

Borr Drilling Announces Patrick Schorn To Transition From CEO To Executive Chairman Of The Board Of Directors

Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) has outperformed the market over the past 15 years by 3.27% on an annualized basis producing an average annual return of 15.69%. Currently, Texas Instruments has a market capitalization of $195.86 billion. 
Buying $1000 In TXN: If an investor had bought $1000 of TXN stock 15 years ago, it would be worth $8,890.31 today based on a price of $215.59 for TXN at the time of writing.
<h3>Texas Instruments's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751488219_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Texas Instruments 15 Years Ago Would Be Worth This Much Today

<ul>
<li>Borr financing package to increase liquidity by $200 million, strengthening balance sheet for continued growth</li>
<li>Bruno Morand to become CEO effective September 1, 2025, following a thorough succession planning process</li>
<li>Patrick Schorn to transition from CEO to Executive Chairman of the Board of Directors, providing continuity and expanded leadership bandwidth, with the current Chairman to remain as a Director</li>
</ul>
HAMILTON, Bermuda, July 2, 2025 /PRNewswire/ -- Borr Drilling Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>, ", Borr", , ", Borr Drilling", or the ", Company", ))) has announced today that the Company has received commitments from certain commercial banks to: 1) increase existing super senior RCF (SSRCF) to $200 million; 2) reallocate the existing $45 million Guarantee Facility from super senior to senior secured (freeing up $45 million of capacity under the SSRCF); &nbsp;and 3) add a new $35 million senior secured RCF, subject to a $100 million equity raise. Additionally, the Company has obtained more favorable terms on the financial covenants in these facilities, including a reduction in the minimum liquidity covenant.
The changes to the facilities, together with a proposed $100 million equity raise separately announced by the Company, are expected to increase the Company's available liquidity by more than $200 million. Together, these moves would strengthen the Company's financial position in order to support continued execution of its long-term strategy as well as the pursuit of potential value-added growth opportunities and industry consolidation.
Borr also announces today that pursuant to the Company's multi-year succession planning process, the Board of Directors has reached a unanimous decision to appoint Mr. Bruno Morand as successor to Chief Executive Officer, Mr. Patrick Schorn, effective September 1, 2025.
At the time of the transition, Mr. Schorn will become Executive Chairman of the Company's Board of Directors, while current Chairman Mr. Tor Olav Trøim will continue to serve as a Director of the Board. Additionally, current Director Mr. Dan Rabun (former Chief Executive Officer and Chairman at Ensco plc) will become Lead Independent Director, ensuring the continuity of independent and objective leadership on behalf of Borr Drilling's shareholders.

Borr Drilling Announces Bruno Morand To Become CEO Effective September 1, 2025

SeaStar Medical Holding Corporation shares are trading higher after receiving confirmation from Nasdaq that it has met the minimum $2.5 million stockholders' equity requirement.

SeaStar Medical Regains Nasdaq Compliance

Borr Drilling shares are trading lower after the company announced a $100 million offering of approximately 50 million shares.

Borr Drilling Limited (the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>) announces today its plans for a public offering seeking to raise $100 million in gross proceeds though an offering of approximately 50 million shares.
The Company plans to use the proceeds from the offering for general corporate purposes, which may include debt service, capital expenditures and funding of working capital.
DNB Carnegie, Clarksons Securities, Citigroup and Goldman Sachs &amp; Co. LLC are joint bookrunners for the offering.

Offerings

Borr Drilling Launches $100M Public Offering Of ~50M Shares To Fund Corporate Needs, Including Debt And Capital Expenditures

Mercury Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCY#NASDAQ">MRCY</a>, <a href="http://www.mrcy.com/">www.mrcy.com</a>))), a technology company that delivers mission-critical processing to the edge, today announced it has been selected by the U.S. Department of Defense (DoD) for funding through its Industrial Base Analysis and Sustainment (IBAS) Program to develop a next-generation RF signal conditioning multi-chip package (MCP). The IBAS Program aims to improve the readiness and competitiveness of the defense industrial base through investments in high-priority domestic technologies and supply chains.
Under a two-year, $8.5 million contract with commercial partner Systems Innovation Engineering, Mercury will develop and demonstrate a new solution designed to enhance the performance and cost of X-band Active Electronically Steered Array (AESA) radars used in air, sea, and ground-based applications. This ultra-compact signal conditioning package will leverage Mercury expertise and innovation in microwave and mixed signal technologies to reduce the size, weight, and power requirements of these integrated assemblies by more than 80% compared to existing hardware. By leveraging state-of-the-art processes, this capability will be more producible, affordability will be improved, and high-volume missions will be enabled.

MRCY

Mercury Systems Chosen By U.S. DoD For $8.5M IBAS Funding To Develop Next-Gen RF Signal Conditioning Multi-Chip Package

UMH Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMH#NYSE">UMH</a>, TASE: UMH))) closed on the acquisition of two manufactured home communities, located in Conowingo, Maryland, for a total purchase price of $14.625 million. These communities contain 191 developed homesites, of which 79% are occupied. They are situated on approximately 82 acres.

UMH Properties Closes Acquisition Of Two Manufactured Home Communities, Located In Conowingo, Maryland, For A Total Purchase Price Of $14.625M

Gold may have dominated headlines during the first half of 2025, rising more than 25%, but it is no longer the sole shiny option for investors. While gold&#8217;s sharp growth is starting to raise valuation questions, a more subdued shift is underway in silver, platinum, and even palladium. <a href="https://www.benzinga.com/etfs">ETFs that </a><a href="https://www.benzinga.com/etfs" target="_blank" rel="noopener">track these</a> less-watched metals are gaining popularity, driven by a combination of macroeconomic tailwinds, a weakening U.S. dollar, and speculation surrounding the Fed&#8217;s next move.
Also Read: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/07/46231169/these-etfs-gain-as-dollar-slips-and-rate-cut-bets-rise">These ETFs Gain As Dollar Slips And Rate Cut Bets Rise</a>
<h2 class="wp-block-heading">The Gold Standard, Still?</h2>
Gold&#8217;s rise has been impressive. The SPDR Gold Shares ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), the biggest and most liquid bullion-backed ETF, increased almost 26% year-to-date, even touching all-time highs in April. Its rally has been driven by rate-cut hopes, geopolitical tensions, and a dollar that&#8217;s lost 11%—its worst first-half performance in over three decades.
But there&#8217;s a caveat. RBC Capital Markets warned in April that gold may now be overpriced from a macroeconomic perspective. The rally, the analysts contend, has been fueled more by fear than by fundamentals. And fear, unlike bullion, doesn&#8217;t come with an ounce measurement.
Also Read: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45869385/silvers-35-breakout-the-best-etfs-for-the-bullish-ride">Silver&#8217;s $35 Breakout: The Best ETFs For The Bullish Ride</a>
<h2 class="wp-block-heading">Platinum, Silver Step Into The Spotlight</h2>
While that&#8217;s happening, other precious metals are making their own comeback. Platinum leaped more than 26% in June alone. Constrained supply conditions and a jump in demand from Chinese jewelry markets have fueled the surge. Mix in speculative demand from both the U.S. and China, and you&#8217;ve got a metal playing catch-up.
Silver and palladium aren&#8217;t quiet either. The iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>) and Sprott Physical Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSLV#NYSE">PSLV</a>) rose consistently as <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45847216/silver-supercycle-you-never-have-enough-of-it-hedge-fund-analyst-says-as-50-level-looms">investors search for discounted alternatives</a> to gold. Silver&#8217;s dual position as both an industrial metal and a precious metal lends it a unique appeal in the current climate, where inflation risk persists and economic statistics are mixed.
This volatile environment has generated a surge in interest in diversified and targeted metals ETFs. Prices of the Aberdeen Standard Physical Platinum Shares ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPLT#NYSE">PPLT</a>) and Sprott Physical Platinum and Palladium Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPPP#NYSE">SPPP</a>) have shot up in the first half of this year, suggesting increased flows, while the Invesco DB Precious Metals Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBP#NYSE">DBP</a>), holding a blend of gold and silver futures, is growing in popularity among tactical asset allocators.
At the same time, multi-metal mining ETFs, such as the iShares MSCI Global Metals &amp; Mining Producers ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/PICK#BATS">PICK</a>), are gaining traction among investors seeking exposure to commodity prices indirectly through producers and refiners.
<h2 class="wp-block-heading">What&#8217;s Behind The Move?</h2>
Dollar Weakness: As the <a href="https://www.benzinga.com/topic/us-dollar">greenback </a>hits <a href="https://www.benzinga.com/markets/economic-data/25/06/46146713/trump-dollar-outlook-tariffs-debt">multi-decade lows</a>, dollar-denominated assets such as precious metals gain attractiveness.
Rate-Cut Buzz: Markets are expecting at least two Fed rate cuts this year, a situation that traditionally favors metal prices.
Valuation Catch-Up: Metals such as platinum remain significantly below all-time highs and are attractive on a relative basis.
<h2 class="wp-block-heading">From Gold to What's Next</h2>
If the first six months of 2025 belonged to gold, then the second half could be remembered for what comes after it. Whether it&#8217;s the breakout of silver, the rise of platinum, or a strategic blend of metals, ETF investors appear poised to diversify through uncertainty, one ounce at a time.
Read Next:<a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/07/46231393/trumps-tax-blitz-is-an-etf-game-changer-are-you-ready"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/07/46231393/trumps-tax-blitz-is-an-etf-game-changer-are-you-ready">Trump&#8217;s Tax Blitz Is An ETF Game-Changer—Are You Ready?</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

Commodities

ETFs

PICK

PPLT

PSLV

SPPP

Gold Isn't The Only Game In Town—Precious Metals ETFs Are Casting A Wider Net

<ul>
<li>Implemented a workforce reduction of approximately 25% of current and planned roles in July 2025, primarily in the areas supporting early-stage research and development and support functions.</li>
<li>The workforce reduction is expected to provide annual cash compensation cost savings of approximately $15 million and offsets additional expenses expected based on the accelerated timelines for the 4FRONT clinical trials and BLA preparation, which supports the Company's cash runway into 2028, as previously guided.</li>
</ul>

FDMT

4D Molecular Therapeutics Cuts Workforce By 25% In July 2025 To Save $15M Annually, Extend Cash Runway Into 2028

Health Care

Press Releases

Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024

Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma

Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025

Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference

Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments

Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma

Comments

Lyell Immunopharma

Interés en corto

Lyell Immunopharma (NASDAQ:LYEL) Bolsa, Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL